Learn More
Gibco™ Human Activin A Recombinant Protein
Recombinant Protein
$556.00 - $14870.00
Specifications
| Accession Number | P08476, Q04998 |
|---|---|
| For Use With (Application) | Bioactivity |
| Formulation | PBS with no preservative |
| Gene ID (Entrez) | 16323, 3624 |
| Molecular Weight (g/mol) | 25 kDa |
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
|---|---|---|---|---|---|---|---|---|---|
| Catalog Number | Mfr. No. | Quantity | Price | Quantity | |||||
PHC9561
|
Gibco™
PHC9561 |
100 μg |
Each for $3,980.00
|
|
|||||
PHC9563
|
Gibco™
PHC9563 |
1 mg |
N/A
|
N/A | |||||
| Please call Customer Service at 1-800-234-7437 or send an email to help@thermofisher.com for assistance. | |||||||||
PHC9564
|
Gibco™
PHC9564 |
10 μg |
Each for $556.00
|
|
|||||
Description
Carrier-Free Reconstitution: We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute lyophilized recombinant human Activin A in sterile PBS containing 0.1% human serum albumin. Further dilutions should be made in low endotoxin medium or a buffered solution containing a carrier protein such as heat inactivated FCS or tissue culture grade BSA. Storage: Store this lyophilized preparation at = -20°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at = -20°C. Avoid repeated freeze/thaw cycles.
Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I ( I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins, composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling; and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Activin A mutations are associated with fibrodysplasia ossificans progressive.Specifications
| P08476, Q04998 | |
| PBS with no preservative | |
| 25 kDa | |
| Purified | |
| RUO | |
| activin A; activin beta-A chain; BMP7; BMP-7; Bone morphogenetic protein 7; EDF; Eptotermin alfa; erythroid differentiation factor; erythroid differentiation protein; follicle-stimulating hormone-releasing protein; FRP; FSH-releasing protein; INHB; Inhba; inhibin B subunit; inhibin beta A chain; inhibin beta A protein; inhibin beta A subunit; inhibin beta-A; inhibin beta-A-subunit; inhibin beta-subunit; inhibin subunit beta A; inhibin, beta A; inhibin, beta A (activin A, activin AB alpha polypeptide); Inhibin, beta-1; OP1; OP-1; Osteogenic protein 1; unnamed protein product | |
| Inhba | |
| Protein | |
| Human | |
| -20°C | |
| ED50 = 0.5 - 5 ng/mL; determined by the dose-dependent proliferation of MPC-11 cells. | |
| <1 EU/ml | |
| HEK293 cells | |
| Recombinant, Ligand | |
| Activins | |
| Gibco |
| Bioactivity | |
| 16323, 3624 | |
| Human Activin A | |
| -20°C | |
| <1 EU/mL | |
| Activin A | |
| ED50 = 0.5 - 5 ng/mL; determined by the dose-dependent proliferation of MPC-11 cells. | |
| Unconjugated | |
| Recombinant | |
| Carrier-Free | |
| Inhibition of Proliferation of MPC11 cells | |
| Dry Ice | |
| Growth Factors & Receptors | |
| Lyophilized | |
| Neurobiology, Stem Cell Research, Differentiation | |
| >95% by SDS-PAGE |